Abstract
HAEMOPHILIA B (or Christmas disease) is an inherited, X-linked bleeding disorder caused by mutations in the gene for clotting factor IX. There is a rare class of patients, exemplified by haemophilia B Leyden1, who suffer from haemophilia B as children but improve after puberty. In these patients, plasma factor IX concentrations are less than 10% of normal during childhood, but after puberty they gradually rise to between 40 and 80% of normal. Mutations clustered around the main transcription start point (defined as +1 (ref. 2)) have been reported in seven of these patients (at −20 (refs 1, 3, 4); −6 (refs 5, 6) and +13 (refs 7, 8)). To determine how these mutations interfere with factor IX expression, we have assayed for transcription factors binding to this area and have identified a nuclear factor-1 liver (NF1-L) binding site9 (−99 to −76) and a binding site for the CCAAT/enhancer binding protein (C/EBP)10 (+1 to +18). We show that the A → G mutation at +13 prevents the binding of C/EBP to this site. Furthermore, we show that C/EBP is capable of transactivating a cotransfected normal factor IX promoter but not the mutant promoter. This is the first natural mutation to be reported which disrupts a C/EBP binding site and is an illustration of the importance of this transcription factor in humans.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Veltkamp, J. J., Meilof, J., Remmelts, H. G., Van der Vlerk, D. & Loeliger, E. A. Scand. J. Haemat. 7, 82–90 (1970).
Anson, D. S. et al. EMBO J. 3, 1053–1060 (1984).
Briët, E., Bertina, R. M., Van Tilburg, N. H. & Veltkamp, J. J. New Engl. J. Med. 306, 788–790 (1982).
Reitsma, P. H., Bertina, R. M., Ploos van Amstel, J. K., Riemens, A. & Briët, E. Blood 72, 1074–1076 (1988).
Kurachi, K., Hirosawa, S., Fahner, J. B., Wu, C. T. & Salier, J. P. Thromb. Haemostasis 62, 154 (1989).
Attree, O., Vidaud, M., Vidaud, D., Lavergne, J. M. & Goosens, M. Thromb. Haemostasis 62, 8 (1989).
Reitsma, P. H., Mandalaki, T., Kasper, C. K., Bertina, R. M. & Briët, E. Blood 73, 743–746 (1989).
Crossley, P. M., Winship, P. R., Black, A., Rizza, C. R. & Brownlee, G. G. Lancet i, 960 (1989).
Paonessa, G., Gounari, F., Frank, R. & Cortese, R. EMBO J. 7, 3115–3123 (1988).
Landschulz, W. H., Johnson, P. F., Adashi, E. Y., Graves, B. J. & McKnight, S. L. Genes Dev. 2, 786–800 (1988).
Fair, D. S. & Bahnak, B. R. Blood 64, 194–204 (1984).
Aden, D. P., Fogel, A., Plotkin, S., Damjanov, I. & Knowles, B. B. Nature 282, 615–616 (1979).
Nowock, J., Borgmeyer, U., Püschel, A. W., Rupp, R. A. W. & Sippel, A. E. Nucleic Acids Res. 13, 2045–2061 (1985).
Gronostajski, R. M. Nucleic Acids Res. 15, 5545–5559 (1987).
Ryden, T. A. & Beemon, K. Molec. cell. Biol. 9, 1155–1164 (1989).
Vinson, C. R., Sigler, P. B. & McKnight, S. L. Science 246, 911–916 (1989).
Huang, M-N., Smith, K., Evans, J. P., Wolde, S. T. & High, K. A. Thromb. Haemostasis 62, 81 (1989).
Levitt, N., Briggs, D., Gil, A. & Proudfoot, N. J. Genes Dev. 3, 1019–1025 (1989).
Friedman, A. D., Landschulz, W. H. & McKnight, S. L. Genes Dev. 3, 1314–1322 (1989).
Santoro, C., Mermod, N., Andrews, P. C. & Tjian, R. Nature 324, 218–224 (1988).
Briët, E., Wijnands, M. C. & Veltkamp, J. J. Ann. Intern. Med. 103, 225 (1985).
Martin, D. I. K., Tsai, S-F. & Orkin, S. H. Nature 338, 435–438 (1989).
Birkenmeier, E. H. et al. Genes Dev. 3, 1146–1156 (1989).
Graves, B. J., Johnson, P. F. & McKnight, S. L. Cell 44, 565–576 (1986).
Gorski, K., Carneiro, M. & Schibler, U. Cell 47, 767–776 (1986).
Dignam, J. D., Lebovitz, R. M. & Roeder, R. G. Nucleic Acids Res. 11, 1475–1489 (1983).
Lamb, P., Watt, P. & Proudfoot, N. J. Progress in Clinical and Biological Research, Hæmoglobin Switching Vol. 316, 269–278 (Liss, New York, 1989).
Graham, F. L. & van der Eb, A. J. Virology 52, 456–467 (1973).
Beddington, R. S. P., Morgernstern, J., Land, H. & Hogan, A. Development 106, 37–46 (1989).
Herbomel, P., Bourachot, B. & Yaniv, M. Cell 39, 653–662 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crossley , M., Brownlee, G. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature 345, 444–446 (1990). https://doi.org/10.1038/345444a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/345444a0
This article is cited by
-
Functional categorization of gene regulatory variants that cause Mendelian conditions
Human Genetics (2024)
-
Highly diversified core promoters in the human genome and their effects on gene expression and disease predisposition
BMC Genomics (2020)
-
Mutations in the promoter region of the aldolase B gene that cause hereditary fructose intolerance
Journal of Inherited Metabolic Disease (2010)
-
Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation
Nature Genetics (1993)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.